☰

Tian Ding, Ph.D. - Publications

Affiliations: 
2009 The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Cell Biology, Biostatistics Biology, Genetics, Oncology
Tree Info Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Leng X, Ding T, Lin H, Wang Y, Wu Y, Arlinghaus RB. WITHDRAWN: Requirement of lipocalin 2 in breast cancer. Advances in Enzyme Regulation. PMID 19914274 DOI: 10.1016/J.Advenzreg.2009.10.001  0.444
2009 Leng X, Ding T, Lin H, Wang Y, Hu L, Hu J, Feig B, Zhang W, Pusztai L, Symmans WF, Wu Y, Arlinghaus RB. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Research. 69: 8579-84. PMID 19887608 DOI: 10.1158/0008-5472.Can-09-1934  0.504
2009 Leng X, Ding T, Arlinghaus R. Requirement of lipocalin 2 for hematopoietic and solid tumor malignancies. Advances in Enzyme Regulation. 49: 142-6. PMID 19344630 DOI: 10.1016/J.Advenzreg.2009.01.010  0.458
2008 Leng X, Lin H, Ding T, Wang Y, Wu Y, Klumpp S, Sun T, Zhou Y, Monaco P, Belmont J, Aderem A, Akira S, Strong R, Arlinghaus R. Lipocalin 2 is required for BCR-ABL-induced tumorigenesis. Oncogene. 27: 6110-9. PMID 18663364 DOI: 10.1038/Onc.2008.209  0.449
Show low-probability matches.